Archives ipo

by in
Entry Author Date Location
At Summer’s End, Can Crossover Winds Stay At Biotech’s Back? 09/01/15 National
CRISPR Cash: Intellia The Latest Gene-Editing Firm To Nab Big Money 09/01/15 Boston
Texas Roundup: Favor, UT-San Antonio, Yan Engines, Health Wildcatters 08/28/15 Texas
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO 08/24/15 Texas
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
RainDance Technologies Cancels Long-Awaited IPO 08/24/15 Boston
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
Seattle E-Retailer Zulily Sells to QVC In Deal Worth $2.4 Billion 08/17/15 Seattle
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
Aimmune Prices Upsized $160M IPO, Climbs Higher in Debut 08/06/15 San Francisco
Roundup: New Money for FlexGen, Neos, MacroFab, Castle & Other News 08/03/15 Texas
Boston’s HubSpot Axes Marketing Exec Over Book Manuscript 07/29/15 Boston
With $550M Fund, Deerfield Management Tackles Early Stage Biotech 07/28/15 New York
Wisconsin Roundup: Capital Midwest, Healthfinch, TAI, & More 07/28/15 Wisconsin
Seattle Roundup: Acquisitions by Zillow, TUNE, Remitly, & More 07/24/15 Seattle
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
After $103M IPO, Rapid7 Stock Up in Early Trading 07/17/15 Boston
Texas Roundup: SailPoint, DEC, Neos, Sanofi, NASA & XPrize 07/17/15 Texas
Rapid7 Prices IPO at $16 Per Share as Cybersecurity Takes Center Stage 07/16/15 Boston
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
Neos Therapeutics, Maker of ADHD Drug Delivery System, Files IPO 07/13/15 Texas
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
Page 1 of 17 next page »